David M. Jablons

OncoDaily

News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary

Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me

January, 2025

David M. Jablons

Jul 24, 2024, 13:40 | Blog

Collin Blakely: Neoadjuvant Osimertinib for the Treatment of Non–Small Cell Lung Cancer

Collin Blakely, Associate Professor of Thoracic Medical Oncology and Clinical Scientist at UCSF, shared a…

Jul 21, 2024, 15:37 | Insight

Neoadjuvant osimertinib for resectable EGFR NSCLC

Stephen V Liu shared on X a recent paper by Collin M. Blakely et al.…

Jul 21, 2024, 13:36 | Blog

Rami Manochakian: Neoadjuvant osimertinib in stage I-IIIA EGFRm NSCLC did not meet primary endpoint

Rami Manochakian shared a post on X: ''Hot off the press. Neoadjuvant Osimertinib for the…

All: 3 Posts: 1 - 100

'

FDA approved sotorasib with panitumumab for KRAS G12C-mutated colorectal cancer

'

Oncologist Near Me - Vivek Subbiah: Pionner of Precision Oncology

'

Monica Bertagnolli is ending her tenure as NIH director

'

Karen Knudsen: Clinical trials are the most advanced form of cancer care

'

NEW PAPER ALERT: Efficacy of CDK4/6 Inhibitors and Endocrine Therapy in HR+/HER2- Advanced Breast Cancer by PAM50 Subtype: SOLTI-1801 CDK-PREDICT Results

Special Coverage

ESMO 2024 Congress
September 13-17, 2024
ASCO Annual Meeting
May 30 - June 4, 2024
Yvonne Award 2024
May 31, 2024
OncoThon 2024, Online
Feb. 15, 2024
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023